Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Deals
InflaRx and Staidson Amend Deal to Advance Vilobelimab Regulatory Filing in China
January 26, 2025
Company
Drug
Elpiscience Receives IND Approval for ES014 in China
January 27, 2025
Company
Deals
Ablaze Pharma and Yonghe Partner for Targeted Radiotherapy Development
January 26, 2025
Company
Drug
InnoCare Pharma’s Orelabrutinib Placed on Partial Clinical Hold by FDA
January 26, 2025
Company
Drug
Hainan Poly Pharm Receives FDA Approval for Generic Lincomycin
January 26, 2025
Company
Drug
Innovent Biologics’ GFH925 Receives Breakthrough Therapy Designation
January 26, 2025
Policy / Regulatory
Sichuan Healthcare Security Administration Announces VBP for Oral Implant Systems
January 26, 2025
Company
Drug
Junshi Biosciences’ PD-1 Inhibitor Tuoyi Faces FDA Review Delay
January 27, 2025
Company
Drug
Huadong Medicine’s Lanluma V and X Approved for Use in Hainan
January 27, 2025
Company
Drug
Antengene and MSD Collaborate on Global Clinical Study for ATG-037
January 27, 2025
Company
Drug
IASO Biotherapeutics Receives FDA Approval for CT103A IND Application
January 27, 2025
Company
Deals
Shenzhen Würzburg Dynamics Raises RMB 100 Million in Series A Financing Round
January 27, 2025
1
2
…
1,063
1,064
1,065
1,066
1,067
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?